Table 1.
Known Functions of the Endocannabinoid System Along the Upper Alimentary Tract
Function | Brief summary | Related studies |
---|---|---|
Appetite regulation | 1. Stimulates appetite, especially high energy, fatty foods | Argueta and DiPatrizio18 |
2. Induces hyperphagia, potential target for obesity therapy, generates hunger signal | DiPatrizio et al.17 | |
DiPatrizio et al.16 | ||
Nociception/emesis | 1. Stimulation of CB1 receptor in CNS leads to nausea, therapeutic target for antiemetic effect of exogenous cannabinoid therapy | Van Sickle et al.19 |
Rock and Parker71 | ||
Motility | 1. Multiple receptors (CB1 and CB2) thought to influence contractile and relaxant forces in stomach | Hornby and Prouty10 |
2. Modulates intestinal propulsion, GPR55 inhibits whole gut transit time, modulation of cholinergical and vagal stimulation of upper GI tract | Yuece et al.12 | |
Storr et al.21 | ||
3. Enhances gut motility in setting of inflammation | Izzo et al.24 | |
Yang et al.26 | ||
Li et al.27 | ||
Gastric acid and intestinal secretions | 1. Exhibits antisecretory effects on gastric acid | Adami et al.15 |
2. Implicated in mitigating inflammation and mucosal damage in GERD | Calabrese et al.25 | |
3. Effect on transient lower esophageal relaxation | Lehmann et al.33 | |
Inflammation and immunity | 1. Anti-inflammatory effects in esophageal reflux disease | Calabrese et al.25 |
2. CB2 receptor downregulates inflammation and associated hypermotility in disease state | Izzo23 | |
Analgesia | 1. Increases pain threshold | Clapper et al.65 |
Malik et al.66 |
CNS, central nervous system; GERD, gastroesophageal reflux disease; GI, gastrointestinal; GPR55, G-protein receptor 55.